Clinical Trial: Construction of a high-risk population identification and early screening pathway for pancreatic lesions based on the PANCREAS scale (China)

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction of a high-risk population identification and early screening pathway for pancreatic lesions based on the PANCREAS scale'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130486

Registration Time: 2026/08/20

Type: Observational study

Primary Sponsor: Peking Union Medical College Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335486

Published by HT Digital Content Services with permission from Health Daily Digest....